-CaMKII signaling can also activate TAK1-NLK kinases, which inhibit TCF/β-catenin signaling. Wnt5a stimulation of p38 kinase via MKK3/6 is required for PDE6 activation and in addition activates transcription factor ATF2. Conflicting data exist regarding Dvl involvement. (C) Wnt-RAP1 signaling. Wnt8 activates CKIε, which phosphorylates and targets SIPA1L1, a Rap1-specific GAP (GTPase-activating protein), for degradation, thereby enhancing Rap1 activation. Rap1 regulates actin cytoskeleton and/or cell adhesion during vertebrate gastrulation. (D) Wnt-ROR2 signaling. ROR2 is a RTK that binds Wnt5a. During gastrulation in Xenopus, Wnt5a/ROR2 activates a PI3K-Cdc42-MKK7-JNK pathway, resulting in activation of ATF2 and cJUN and the expression of PAPC. ROR2 also binds to FilaminA (an actin-binding protein) and promotes filopodia formation. Wnt5a/ROR2 signaling antagonizes β-catenin signaling. (E) Wnt-PKA signaling. This pathway is implicated in myogenesis in mice. Wnt1/Wnt7a activates the G protein and AC to increase cAMP levels, which activates PKA and transcription factor CREB and myogenic gene expression. Abbreviations AC, adenylyl cyclase; AP2, adaptor protein complex 2; aPKC, atypical protein kinase C; ATF2, activating transcription factor 2; β-cat, β-catenin; βarr2, β-arrestin 2; CaMKII, Ca 2+ /calmodulin-dependent protein kinase 2; Cdc42, cell division cycle 42 protein; CapZIP, CapZ-interacting protein; CKI, casein kinase 1; CNA, Calcineurin; CREB, cAMP response element-binding factor; Daam1, dishevelled associated activator of morphogenesis; Dgo, diego; Div, diversin; Dsh, Drosophila dishevelled; Dub, duboraya; Dvl, dishevelled; FlnA, filamin A; Fmi, flamingo; Fz, Frizzled; Fy, fuzzy; G, G protein αβγ subunits; GSK3, glycogen synthase kinase 3; Int, inturned; Inv, inversin; JNK, C-Jun N-terminal kinase; cJUN, jun oncogene; LGL, lethal giant larvae; LRP5/6, low-density lipoprotein receptor-related protein 5/6; MAP1B, microtubule-associated protein 1B; MKK, mitogenactivated protein kinase; MRLC, myosin regulatory light chain; mTOR, mammalian target of rapamycin; NF-AT, nuclear factor of activated T cells; NLK, nemo-like kinase; p38, mitogen-activated protein kinase 14; PAPC, paraxial protocadherin; PAR, partitioning-defective; PDE6, phosphodiesterase 6; PI3K, phosphoinositide 3-kinases; Pk, prickle; PKA, protein kinase A; PKC, protein kinase C; PKG, protein kinase G; PLC, phospholipase C; PXN, paxillin; Rac1, Ras-related C3 botulinum toxin substrate 1; Rap1, small GTPase; RhoA, Ras-homologous A; Rock2, Rho-associated kinase 2; ROR2, receptor tyrosine kinase-like orphan receptor 2; RTK7, receptor tyrosine kinase 7; RYK, receptor related to tyrosine kinase; Src, avian sarcoma virus transforming gene; SIPA1L1, signal-induced proliferation-associated 1 like 1; Stbm, strabismus; TAK1, TGF-β activated kinase 1; TCF, T cell-specific transcription factor; TSC2, tuberous sclerosis complex 2; TK, tyrosine kinase; Vangl2, van gogh-like 2; XRNF185, Xenopus ring finger protein 185.
